Impact of Preoperative Weight Loss and Obesity Medications on Postoperative Weight Loss After Sleeve Gastrectomy
Year: 2026
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Preoperative weight loss for bariatric surgery may optimize postoperative outcomes. Antiobesity medications (AOMs) may impact postoperative weight loss. This study evaluated preoperative GLP-1 receptor agonist use on total weight loss (%TWL) after sleeve gastrectomy. METHODS: This was a retrospective cohort study of sleeve gastrectomy patients at an academic institution, 2020-2024. Patients were categorized by preoperative weight change: preoperative weight gain (PWG), 0%-5% preoperative weight loss (PWL), 5%-10% PWL, and > 10% PWL. Demographics, comorbidities, AOM use, and %TWL at 2 months, 6 months, and 1 year post surgery were analyzed. Logistic regression identified predictors of achieving > 10% PWL. RESULTS: A total of 436 patients were included: PWG (n = 75), 0%-5% PWL (n = 173), 5%-10% PWL (n = 126), and > 10% PWL (n = 62). %TWL differed significantly between groups at all time points, including 1 year post surgery (PWG: 22.3% ± 9.9%, 0%-5% PWL: 25.9% ± 8.8%, 5%-10% PWL: 27.1% ± 8.8%, > 10% PWL: 31.7% ± 9.9%; p < 0.0001). Overall, 41.5% of patients used AOMs preoperatively, from 22.7% in the PWG group to 64.5% in the > 10% PWL group (p < 0.001). AOM use was significantly associated with > 10% PWL (OR 3.3, 95% CI 1.8-6.1). CONCLUSIONS: AOM use was associated with > 10% preoperative weight loss, and greater preoperative weight loss was also coupled with higher cumulative postoperative %TWL.
Source: Obesity
DOI: 10.1002/oby.70321
Institution: Yale University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7235420389
